Eugenol potentiates cisplatin anti‐cancer activity through inhibition of ALDH‐positive breast cancer stem cells and the NF‐κB signaling pathway by Islam, Syed S., Al‐Sharif, Ibtehaj, Sultan, Ahlam, Al‐Mazrou, Amer, Remmal, Adnane, Aboussekhra, Abdelilah

Get full text

PAC exhibits potent anti-colon cancer properties through targeting cyclin D1 and suppressing epithelial-to-mesenchymal transition by Al-Qasem, Abeer, Al-Howail, Huda A., Al-Swailem, Mashael, Al-Mazrou, Amer, Al-Otaibi, Basem, Al-Jammaz, Ibrahim, Al-Khalaf, Huda H., Aboussekhra, Abdelilah

Get full text

PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis by Mansour, Fatmah A., Al-Mazrou, Amer, Al-Mohanna, Falah, Al-Alwan, Monther, Ghebeh, Hazem

Get full text

A unique STK4 mutation truncating only the C-terminal SARAH domain results in a mild clinical phenotype despite severe T cell lymphopenia: Case report by Al-Saud, Bandar, Alajlan, Huda, Alruwaili, Hibah, Almoaibed, Latifa, Al-Mazrou, Amer, Ghebeh, Hazem, Al-Alwan, Monther, Alazami, Anas M

Get full text

Differential marker expression by cultures rich in mesenchymal stem cells by Wetzig, Andrew, Alaiya, Ayodele, Al-Alwan, Monther, Pradez, Christian Benedict, Pulicat, Manogaran S, Al-Mazrou, Amer, Shinwari, Zakia, Sleiman, Ghida Majed, Ghebeh, Hazem, Al-Humaidan, Hind, Gaafar, Ameera, Kanaan, Imaduddin, Adra, Chaker

Get full text

3075 – COMPARATIVE CLASSIFICATION OF HSCS SUBSETS IN HUMAN CORD BLOOD AND BONE MARROW SAMPLES:IMPLICATIONS FOR CELL THERAPY by Gaafar, Ameera, Alaiya, Ayodele, Yousif, Rama, Shinwar, Zakia Shinwar, Subramanian, Pulicat, Al-Mazrou, Amer, Al-Humaidan, Hind, Alhussein, Khalid

Get full text

Severe Combined Immunodeficiency from a Homozygous DNA Ligase 1 Mutant with Reduced Catalytic Activity but Increased Ligation Fidelity by Alajlan, Huda, Raducanu, Vlad-Stefan, Lopez de los Santos, Yossef, Tehseen, Muhammad, Alruwaili, Hibah, Al-Mazrou, Amer, Mohammad, Reem, Al-Alwan, Monther, De Biasio, Alfredo, Merzaban, Jasmeen S., Al-Mousa, Hamoud, Hamdan, Samir M., Alazami, Anas M.

Get full text

Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers by Ghebeh, Hazem, Sleiman, Ghida Majed, Manogaran, Pulicat S, Al-Mazrou, Amer, Barhoush, Eman, Al-Mohanna, Falah H, Tulbah, Asma, Al-Faqeeh, Khalid, Adra, Chaker N

Get full text

PAC down-regulates estrogen receptor alpha and suppresses epithelial-to-mesenchymal transition in breast cancer cells by Al-Howail, Huda A, Hakami, Hana A, Al-Otaibi, Basem, Al-Mazrou, Amer, Daghestani, Maha H, Al-Jammaz, Ibrahim, Al-Khalaf, Huda H, Aboussekhra, Abdelilah

Get full text

Cellular and molecular profiling of primitive HSC subsets in umbilical cord blood samples: Implications for cellular therapy by Gaafar, Ameera, Al Hussein, Khalid, Alaiya, Ayodele, Alotaibi, Aminah, Hamza, Fatheia Nabil, Iqniebi, Alia, Manogaran, Pulicat, Al-Mazrou, Amer, Barhoush, Iman, Alkaff, Morad, Al-Humaidan, Hind

Get full text

Profiling of normal and malignant breast tissue show CD44high/CD24lowphenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers by Ghebeh, Hazem, Sleiman, Ghida Majed, Manogaran, Pulicat S, Al-Mazrou, Amer, Barhoush, Eman, Al-Mohanna, Falah H, Tulbah, Asma, Al-Faqeeh, Khalid, Adra, Chaker N

Get full text

A unique STK4 mutation truncating only the C-terminal SARAH domain results in a mild clinical phenotype despite severe T cell lymphopenia: Case report by Al-Saud, Bandar, Alajlan, Huda, Alruwaili, Hibah, Almoaibed, Latifa, Al-Mazrou, Amer, Ghebeh, Hazem, Al-Alwan, Monther, Alazami, Anas M

Get full text